GSK to Add 2D Barcoding on Several U.S. Vaccines


By Mia Burns

In a step that supports electronic medical record keeping, GlaxoSmithKline will place two dimensional on both the inner containers and outer boxes of most of the company’s . A 2D barcode is a small square and compared to the current linear barcodes, can hold more information.

The additional capacity of 2D Data Matrix technology allows for product identification, expiration date, and lot number to be encoded on each vaccine product. When healthcare providers have the necessary hardware and software for this technology, they can update their inventory management system, patient records, and vaccination reports automatically. This reduces the need for manual entry of information, which can be susceptible to administrative errors and incomplete record keeping.

“GSK believes 2D barcoding is important because it is an initiative in response to customer needs,” says Dr. Leonard Friedland, VP, scientific affairs and public policy, GSK Vaccines, North America.  “In addition, through the regular electronic scanning of the additional information contained in 2D barcoding, we believe that a more accurate and complete picture of U.S. vaccine usage could emerge.”

Dr. Friedland also told Med Ad News Daily, “GSK’s decision to implement 2D barcoding represents a commitment beyond the pilot initiative, which the Centers for Disease Control and Prevention began in 2011 with support from key organizations, including the FDA, the American Academy of Pediatrics, and other manufacturers.”

The AAP championed discussions on the feasibility of 2D barcoding in 2009 and, as a primary advocate of 2D barcoding, the organization continues to work with stakeholders to create standards and provide office implementation guidance. GSK…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS